A study obtained HLA-A2/GPC3367-specific TCRs by transfecting HLA-A2 with GPC3 into HLA-A2-negative donor DCs and coculturing them with host T cells; the expression of this receptor on T cells enabled them to recognize and kill GPC3-positive HCC cells (188). Here, GPC3 is linked to hepatocellular carcinoma.